FDA Advisors Review Crispr Gene-Editing Treatment for Sickle Cell Anemia

One after another, the men and women testified how a new gene-editing treatment had relieved their suffering from sickle-cell disease. They addressed a Tuesday hearing in which the Food and Drug Administration heard patients and scientists weigh in on what’s likely to be the country’s…